Exclusive

Publication

Byline

US Patent Issued to ExoCoBio on April 21 for "Composition comprising iris-derived exosome as active ingredient" (South Korean Inventor)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,331, issued on April 21, was assigned to ExoCoBio Inc. (Cheongju-si, South Korea). "Composition comprising iris-derived exosome as active ... Read More


US Patent Issued to Albert Einstein College of Medicine on April 21 for "Transdermal delivery formulations" (New Jersey Inventor)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,332, issued on April 21, was assigned to Albert Einstein College of Medicine (Bronx, N.Y.). "Transdermal delivery formulations" was invent... Read More


US Patent Issued to Tris Pharma on April 21 for "Modified release drug powder composition comprising gastro-retentive raft forming systems having trigger pulse drug release" (New Jersey Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,333, issued on April 21, was assigned to Tris Pharma Inc. (Monmouth Junction, N.J.). "Modified release drug powder composition comprising ... Read More


US Patent Issued to Solesence on April 21 for "Method of enhancing the efficacy and stability of ingredients in suspensions" (Illinois Inventor)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,334, issued on April 21, was assigned to Solesence Inc. (Romeoville, Ill.). "Method of enhancing the efficacy and stability of ingredients... Read More


US Patent Issued to SHANGHAI WEI ER BIOPHARMACEUTICAL TECHNOLOGY, SHANGHAI BAOLONG PHARMACEUTICAL, BAOLONG PHARMACEUTICAL, SHANGHAI BAOLONG ANQING PHARMACEUTICAL on April 21 for "Triptolide lignocerate, liposome thereof and preparation method therefor" (Chinese Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,335, issued on April 21, was assigned to SHANGHAI WEI ER BIOPHARMACEUTICAL TECHNOLOGY Co. LTD. (Shanghai), SHANGHAI BAOLONG PHARMACEUTICAL ... Read More


US Patent Issued to The Regents of the University of California on April 21 for "Fusogenic liposome-coated porous silicon nanoparticles" (California, Massachusetts Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,336, issued on April 21, was assigned to The Regents of the University of California (Oakland, Calif.). "Fusogenic liposome-coated porous ... Read More


US Patent Issued to Peking University on April 21 for "Nanoparticle drug targeting JFK and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,337, issued on April 21, was assigned to Peking University (Beijing). "Nanoparticle drug targeting JFK and use thereof" was invented by Lu... Read More


US Patent Issued to Southwest University on April 21 for "Method for preparing nano-immune activator, article and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,338, issued on April 21, was assigned to Southwest University (Chongqing, China). "Method for preparing nano-immune activator, article and... Read More


US Patent Issued on April 21 for "Method for carrying bioactive molecules using nanocarriers" (Turkish Inventor)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,339, issued on April 21. "Method for carrying bioactive molecules using nanocarriers" was invented by Zekeriya Ozmen (Battalgazi/Malatya, ... Read More


US Patent Issued to ZIM LABORATORIES on April 21 for "Extended release composition of 2-(2-Aminothiazol-4-yl)-N-[4-(2{[(2R)-2-hydroxy-2-phenylethyl amino} ethyl) phenyl acetamide" (Indian Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,340, issued on April 21, was assigned to ZIM LABORATORIES Ltd. (Maharashtra, India). "Extended release composition of 2-(2-Aminothiazol-4-... Read More